Advertisement
Advertisement

PAVM

PAVM logo

PAVmed Inc. Common Stock

4.68
USD
Sponsored
-0.50
-9.65%
Jun 09, 15:59 UTC -4
Closed
exchange

After-Market

4.80

+0.12
+2.56%

PAVM Earnings Reports

Positive Surprise Ratio

PAVM beat 13 of 37 last estimates.

35%

Next Report

Date of Next Report
Aug 11, 2026
Estimate for Q2 26 (Revenue/ EPS)
$99.96K
/
-$0.47
Implied change from Q1 26 (Revenue/ EPS)
+354.36%
/
-89.37%
Implied change from Q2 25 (Revenue/ EPS)
+1566.00%
/
-97.88%

PAVmed Inc. Common Stock earnings per share and revenue

On May 14, 2026, PAVM reported earnings of -4.42 USD per share (EPS) for Q1 26, missing the estimate of -0.71 USD, resulting in a -519.05% surprise. Revenue reached 22.00 thousand, compared to an expected 75.48 thousand, with a -70.85% difference. The market reacted with a +1.24% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 4 analysts forecast an EPS of -0.47 USD, with revenue projected to reach 99.96 thousand USD, implying an decrease of -89.37% EPS, and increase of 354.36% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Autonomix Medical, Inc. Common Stock
Report Date
May 27, 2026 For Q4 26
Estimate
-$0.26
Actual
-$0.23
Surprise
+13.27%
logo
Mesa Laboratories Inc
Report Date
May 27, 2026 For Q4 26
Estimate
$0.34
Actual
-$0.75
Surprise
-316.26%
FAQ
For Q1 2026, PAVmed Inc. Common Stock reported EPS of -$4.42, missing estimates by -519.05%, and revenue of $22.00K, -70.85% below expectations.
The stock price moved up 1.24%, changed from $6.45 before the earnings release to $6.53 the day after.
The next earning report is scheduled for Aug 11, 2026.
Based on 4 analysts, PAVmed Inc. Common Stock is expected to report EPS of -$0.47 and revenue of $99.96K for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement